A Novel Phospholipid Derivative of Indomethacin, DP-155 [Mixture of 1-Steroyl and 1-Palmitoyl-2-{6-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]hexanoyl}-sn-glycero-3-phosophatidyl Choline], Shows Superior Safety and Similar Efficacy in Reducing Brain Amyloid in an Alzheimer's Disease Model

Erratum

Correction to "A Novel Phospholipid Derivative of Indomethacin, DP-155 Mixture of 1-Steroyl and 1-Palmitoyl-2-{4-1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamidobutanoyl}-sn-glycero-3-phosophatidyl Choline, Shows Superior Safety and Similar Efficacy in Reducing Brain Amyloid b in an Alzheimer's Disease Model"
In the title, abstract, and abbreviations footnote of the article above Dvir E, Friedman JE, Lee JY, Koh JY, Younis F, Raz S, Shapiro I, Hoffman A, Dahan A, Rosenberg G, et al. (2006) J Pharmacol Exper Ther 318:1248-1256, the chemical composition of DP-155 was misreported. The corrected portion of the composition, with changes noted in bold, appears as follows: {6-1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamidohexanoyl}.
The chemical structure of DP-155 as shown in Fig. 1 is correct.
The online version has been corrected in departure from the print version.
The authors regret this error and apologize for any confusion or inconvenience it may have caused.